Clinical trial
Effects of Artificial Intelligence-based Diabetic Retinopathy Screening on Timely Access to Treatment in Individuals With Diabetes
NCT07236879 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Artificial Intelligence-based Diabetic Retinopathy Screening on Timely Access to Treatment in Individuals With Diabetes
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 8, 2024
- Completion date
- December 31, 2026
- Enrollment
- 922 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.